trending Market Intelligence /marketintelligence/en/news-insights/trending/7mrFhSMQnizmXCY1lDkbAw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In This List

Principia Biopharma prices $210M common stock offering

S&P Global Market Intelligence

Cannabis Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Principia Biopharma prices $210M common stock offering

Principia Biopharma Inc. priced its underwritten public offering of 7.5 million common shares at $28 each.

The South San Francisco, Calif.-based company also granted underwriters a 30-day option to buy up to 1,125,000 additional common shares at the same price.

Principia expects $210 million in gross proceeds from the offering.

The offer is expected to close on or about Oct. 18.

BofA Merrill Lynch, SVB Leerink, and Wells Fargo Securities are acting as joint book-running managers for the offering, while Baird is lead manager, while H.C. Wainwright & Co. is co-manager for the offer.

Principia Biopharma Inc. develops therapies for immunology and oncology.